INTRODUCTION
Being a popular ingredient in Mediterranean cuisine, artichoke was used as a treatment agent since ancient times (1, 10) . Artichoke had an effect on gastro-intestinal tract dysfunction and disorders (2, 5, 10, 14, 15) . This delicious plant showed choleretic, diuretic, and antirheumatic activities as well as a coagulant effect in liver and kidneys (10) (11) (12) 15) . Despite wide application in official and folk medicine (15) , artichoke flower heads are still of great interest among the scientists. During the first part of twentieth century some new effects of artichoke were discovered. This plant turned out to improve liver functioning, protect from liver fat degeneration caused by arsenic compounds as well as decrease cholesterol level (3, 4, 6, 13, 15) . 1990s was an important period in artichoke studies. This decade went into history as the time of cynarin structure discovery and exploration of cell-protection action on isolated secondary hepatocytes and cholesterol biosynthesis decrease (9, 10) .
The lack of side-effects in combination with fetus protection activity makes artichoke remedies and dietary products an important part of a therapy during pregnancy (10, 15 
MATERIALS AND METHODS
Dry artichoke flower heads (inflorescences) was the plant raw material which was selected as the object of research.
The studied solutions were prepared in the following way (7) .
Methanol Solution Preparation 5 g of plant raw material -dry artichoke flower heads (inflorescences) was put into a round-bottom flask with further addition of 125.0 ml of methanol and boiling it in a water bath with a reflux condenser for 1 hour. Later on it was cooled, filtered through "blue stripe" paper filter (solution 1). The solvent was added to 5.0 ml of the obtained solution in amount enough to get 10.0 ml in total volume. Extract Preparation after Hydrolysis 5.0 ml of solution 1 was put into a round-bottom flask with the further addition of 5.0 ml of hydrochloric acid. The obtained solution was boiled in a water bath with a reflux condenser for 30 min. Afterwards it was cooled and put into a 25 ml volumetric flask. The volume was increased with methanol up to the flask mark, then mixed and filtered through "blue stripe" paper filter. The solvent was added to 5.0 ml of the obtained solution in amount enough to get 10.0 ml in total volume. The next step was conduction of a chromatographic analysis.
The chromatographic study of the tested extracts and standard samples solutions was carried out with the help of Agilent 1200 LC/MSD chromatograph which consisted of a pump unit G1312A, degasser G1322A, column thermostat G1316A, autosampler G1367B, diode-matrix detector G1315D and quadrupole mass spectrometer Agilent 6130. Chromatography was carried out under such conditions: a column made of a stainless steel С18 SunFire (150 x 4.6 mm, 3.5 µm); the column temperature -38 0 С; diode-matrix detector detection wavelength was 254 nm, 330 nm, 350 nm, 360 nm, 370 nm. Mass detector detection conditions were the following: ionization -electric spray, scanning in the range of 150-800 m/z (positive and negative ionization); fragmentation -70; gain -1.0; the flow rate of a mobile phase was 1 ml/min; the injected sample volume was 50 µl.
The mobile phase was the following:
Hyperoside, rutin, apigenin-7-glucoside, luteolin-7-glucoside and luteolin solutions as well as caffeic acid, rosmarinic acid and chlorogenic acid solutions in methanol were used as standard solutions.
While working, the following reagents were used: acetonitrile and methanol for gradient chromatography ("FLUKA" (Germany)); formic acid ("FLU-KA" (Germany)); rectified ethanol (according to the Pharmacopoeia requirements), and water.
The obtained data were analyzed using Student's t-test. Table 1 shows the data regarding the retention time of standard substances under the conditions of the studied chromatography technique.
RESULTS AND DISCUSSION
The chromatograms of the standard compounds are shown in Fig. 1-8 Figures 9-10 show chromatograms of the studied solutions. The studied compounds in the solutions tested were identified by retention time as well as by m/z index. Fig. 9 represents the chromatograms of the tested solutions obtained under conditions of positive ionization. Fig. 10 represents the chromatograms of the tested solutions obtained under conditions of negative ionization.
The data regarding the obtained components and their concentrations in the solutions studied are presented in Table 2 .
According to the data presented in Table 2 all the studied standard compounds were identified in the tested methanol extract (7, 8, 13) . The dominant components were apigenin-7-glucoside and chlorogenic acid with concentration of 0.75701% and 0.51378%, respectively. Luteolin, caffeic acid, luteolin-7-glucoside and hyperoside were identified in lower concentration -0.13217%, 0.05216%, 0.03117% and 0.00087%, respectively. Rutin and rosmarinic acid were represented in the tested solution only in trace amounts.
According to the data represented in Table 2 , only 4 compounds -apigenin-7-glucoside, luteolin, chlorogenic acid and luteolin-7-glucoside were identified in the extract after hydrolysis. The concentration of the compounds mentioned above was 0.16639%, 0.02468%, 0.00563% and 0.00242%, respectively.
CONCLUSIONS
New remedies and diet supplements are appearing on the pharmaceutical market in Ukraine and abroad. The conducted research enables further standardization of artichoke-containing drugs and products based on the data provided below.
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